Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Beijing Xuanwu Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Intelligent Diagnosis and Treatment Model for Insomnia Disorder

Recruiting

Conditions: Insomnia

Interventions: Other: Routine clinical treatment

First Posted Date: 2024-04-19

Last Posted Date: 2024-12-10

Lead Sponsor: Xuanwu Hospital, Beijing

Target Recruit Count: 16000

Registration Number: NCT06375447

Locations: 🇨🇳
Xuanwu Hospital, Capital Medical University, Beijing, China
🇨🇳
Beijing Tiantan Hospital, Capital Medical University, Beijing, China
🇨🇳
The First Bethune Hospital of Jilin University, Changchun, China

and more 2 locations

Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy

Phase 4

Completed

Conditions: Cerebral Angiography
Heparinization

Interventions: Drug: Heparin Sodium Injection
Other: No heparinization
Drug: Heparin

First Posted Date: 2024-04-15

Last Posted Date: 2024-04-15

Lead Sponsor: Xuanwu Hospital, Beijing

Target Recruit Count: 180

Registration Number: NCT06365398

Locations: 🇨🇳
Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳
Xuanwu Hospital, Capital Medical University., Beijing, China

DBS for Treatment-resistant Obsessive-compulsive Disorder

Not Applicable

Not yet recruiting

Conditions: Obsessive-Compulsive Disorder (OCD)

Interventions: Device: Deep brain stimulation (DBS)

First Posted Date: 2024-04-11

Last Posted Date: 2024-04-11

Lead Sponsor: Xuanwu Hospital, Beijing

Target Recruit Count: 60

Registration Number: NCT06360991

Locations: 🇨🇳
Xuanwu Hospital, Capital Medical University, Beijing, China

The Prediction of Hemorrhage Transformation by Cerebral Autoregulation in AIS Patient After Endovascular Thrombectomy

Conditions: Endovascular Thrombectomy
Acute Ischemic Stroke
Dynamic Cerebral Autoregulation

Interventions: Procedure: endovascular thrombectomy

First Posted Date: 2024-04-11

Last Posted Date: 2024-08-06

Lead Sponsor: Xuanwu Hospital, Beijing

Target Recruit Count: 300

Registration Number: NCT06361017

Locations: 🇨🇳
Department of Vascular Ultrasonography, Xuanwu Hospital of Capital Medical University, Beijing, Beijing, China

Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome

Not Applicable

Not yet recruiting

Conditions: Tourette's Syndrome

Interventions: Device: Deep Brain Stimulation (DBS)

First Posted Date: 2024-04-11

Last Posted Date: 2024-04-11

Lead Sponsor: Xuanwu Hospital, Beijing

Target Recruit Count: 60

Registration Number: NCT06361004

Locations: 🇨🇳
Xuanwu Hospital, Capital Medical University, Beijing, China

Application of tDCS Stimulation in Controlling Refractory Status Epilepticus

Not Applicable

Recruiting

Conditions: Refractory Status Epilepticus

Interventions: Device: tDCS stimulation
Device: TDCS sham-stimulation

First Posted Date: 2024-04-03

Last Posted Date: 2024-07-31

Lead Sponsor: Xuanwu Hospital, Beijing

Target Recruit Count: 32

Registration Number: NCT06344338

Locations: 🇨🇳
Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China

Comprehensive Assessment of Atherosclerotic Ischemic Stroke Risk and Development of a Prediction Model

Active, not recruiting

Conditions: Carotid Stenosis
Ischemic Stroke

First Posted Date: 2024-03-18

Last Posted Date: 2024-03-18

Lead Sponsor: Xuanwu Hospital, Beijing

Target Recruit Count: 500

Registration Number: NCT06315153

Locations: 🇨🇳
The first hospital of Jilin university, Changchun, Jilin, China
🇨🇳
Xuanwu Hospital, Capital Medical University, Beijing, China

The Therapeutic Effect of Betaine in Syringomyelia

Phase 2

Recruiting

Conditions: Syringomyelia

Interventions: Drug: Betaine
Drug: Placebo

First Posted Date: 2024-03-13

Last Posted Date: 2024-03-13

Lead Sponsor: Xuanwu Hospital, Beijing

Target Recruit Count: 30

Registration Number: NCT06308367

Locations: 🇨🇳
Fengzeng Jian, Beijing, Beijing, China

Revascularization for Symptomatic Non-acute Carotid Artery Occlusion

Recruiting

Conditions: Non-acute Carotid Artery Occlusion

Interventions: Procedure: Carotid Artery Stenting (CAS)
Procedure: Hybrid Surgery
Procedure: Carotid Endarterectomy (CEA)

First Posted Date: 2024-03-12

Last Posted Date: 2024-03-12

Lead Sponsor: Xuanwu Hospital, Beijing

Target Recruit Count: 1000

Registration Number: NCT06303414

Locations: 🇨🇳
Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳
Xuanwu Hospital, Capital Medical University., Beijing, China

A Predictive Model and Scoring System for Severe Complications After Endovascular Thrombectomy

Completed

Conditions: Malignant Cerebral Edema
Acute Ischemic Stroke
Endovascular Thrombectomy
Symptomatic Intracranial Hemorrhage

First Posted Date: 2024-03-04

Last Posted Date: 2024-03-04

Lead Sponsor: Xuanwu Hospital, Beijing

Target Recruit Count: 1500

Registration Number: NCT06290076

Locations: 🇨🇳
Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy